Results

51 - 60 of 376 results for ‘guidelines’.

  • NCSP Sector Update – July 2023

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/ncsp-hpv-screening/news/ncsp-sector-update-july-2023

    ... We are committed to respecting the taonga that is wāhine Māori data, and committed to working in partnership with the National Kaitiaki Group to ensure this data is honoured and used for the benefit of wāhine Māori, and we will continue to work to heal this relationship. Clinical Practice Guidelines The National Cervical Screening Programme (NCSP) Clinical Practice Guidelines 2023 for Cervical Screening in Aotearoa New Zealand are available, and are for use when HPV testing becomes the primary screen for cervical cancer prevention. The Guidelines can be found on the NSU Health Professiona ...

  • COVID-19: Advice for community allied health, scientific and technical providers

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/covid-19/information-for-health-professionals/advice-for-community-allied-health-scientific-and-technical-providers

    ... face-to-face treatment.    The level of PPE required for clinician and patient depends on the infection risk of the patient, and the nature of the care needing to be provided.   Please refer to  PPE guidance for healthcare settings  and specific PPE respiratory physiotherapy guidelines below.   Respiratory physiotherapy guidelines for managing patients with COVID or of unknown COVID status (DOCX, 114 KB) [DOCX, 114 KB] Respiratory physiotherapy guidelines for managing patients with COVID or of unknown COVID status (PDF, 103 KB) [PDF, 103 KB] Clinical rehabilitation for ...

  • Appendix 5: Non-invasive prenatal screening

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-workforce-development/maternity/new-zealand-obstetric-ultrasound-guidelines-online/appendices/appendix-5-non-invasive-prenatal-screening

    Non-invasive prenatal screening (NIPS) is a way of determining the risk of the fetus having certain chromosomal abnormalities. Small fragments of circulating DNA in a pregnant woman’s blood are analysed.   These fragments are free floating and not within cells, unlike most DNA, which is found inside a cell’s nucleus.   They are therefore known as cell-free DNA (cfDNA). During pregnancy, a mixture of cfDNA from the woman’s cells and cells from the placenta are found in the maternal blood.   Evaluation of the cfDNA from the placenta allows screening for certain genetic abnor

  • Health professional resources

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/family-violence-and-sexual-violence/health-professional-resources

    Guidelines Expand all Family Violence Assessment and Intervention Guideline: Child abuse and intimate partner violence (Jun 2016) Family Violence Assessment and Intervention Guideline: Child abuse and intimate partner violence (Jun 2016) Family Violence Assessment and Intervention Guideline: Child abuse and intimate partner violence [DOCX, 2.5 MB] Family Violence Assessment and Intervention Guideline: Child abuse and intimate partner violence [PDF, 3.3 MB] Family Violence Intervention Guidelines: Elder Abuse and Neglect (Aug 2007) Family Violence Intervention Guidelines: Elder Abuse and Neglec ...

  • BSA Provider Toolkit

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/breastscreen-aotearoa/bsa-provider-toolkit

    About the Toolkit This is a basic style guide and has templates and artwork featuring the Time to Screen branding for BreastScreen Aotearoa providers. BreastScreen Aotearoa providers may still have resources using the previous visual identity guidelines. We encourage you to use the new visual identity as you replace or develop new resources. The toolkit is designed to assist providers with producing and printing your own local information as and when needed. More templates will be added over time. Please contact your Portfolio Manager: to approve any new material using the design elements of t ...

  • Informed consent

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/newborn-metabolic-screening-programme/informed-consent

    Offering newborn metabolic screening is an integral part of an LMC’s antenatal and postnatal care, and obtaining informed consent for participation in the NMSP is central to best practice in maternity care. In the case of screening, individuals are not just consenting to a screening test but to the full screening pathway. Informed consent needs to be integrated throughout the screening process. This includes consent to use data for monitoring and reporting purposes and storage and possible future uses of blood spots. The parents/guardians, on behalf of the baby: must be legally competent to

  • 12–13+6 week scan

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-workforce-development/maternity/new-zealand-obstetric-ultrasound-guidelines-online/first-trimester/1213-6-week-scan

    These guidelines were published in 2019 and are awaiting review, due 2022. Some content may be outdated. The 12+ week scan should be considered an early anatomy scan and may include NT assessment as part of combined screening for Down syndrome and other conditions (see   NSU, Antenatal Screening for Down syndrome and other conditions ).   The scan is optimally performed at 12–13+6 weeks’ gestation (see   Antenatal Screening for Down Syndrome and Other Conditions: Guidelines for health practitioners [PDF, 2.6 MB] , Ministry of Health 2013). Indications   Dating ...

  • National Stroke Clot Retrieval Service Improvement Programme

    http://corporat-prod.sites.silverstripe.com/health-services-and-programmes/national-stroke-clot-retrieval-service-improvement-programme

    About the programme Stroke Clot Retrieval (SCR) is the removal of a blood clot blocking a major brain artery using an endovascular technique to restore blood flow and avoid permanent brain damage. SCR is recommended as the standard of care in international stroke guidelines and has substantial benefits in terms of improved outcomes following stroke. Treatment is time sensitive and requires a highly coordinated approach across regional and provider hospitals for efficient diagnoses, transport and treatment at one of the three current SCR centres at Auckland, Capital & Coast and Canterbury h ...

  • Hydrops

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/health-workforce-development/maternity/new-zealand-obstetric-ultrasound-guidelines-online/third-trimester/hydrops

    These guidelines were published in 2019 and are awaiting review, due 2022. Some content may be outdated. Hydrops is defined as fluid within two or more body spaces, for example:   pericardial effusion pleural effusion/s ascites skin oedema. Causes Non-immune (see   Nonimmune Hydrops Fetalis [PDF, 389 KB] [PDF, 389 KB] , NZMFMN 2012) Immune (see   RBC antibodies and thalassemia   below). Ultrasound examination As per   Third-trimester ultrasound examination . Additional views Heart rate and rhythm to exclude fetal cardiac arrhythmia. MCA PSV (see   New Zealand ...

  • Maternity referrals — Auckland

    http://corporat-prod.sites.silverstripe.com/for-health-professionals/hospital-and-specialist-services/maternity-services/maternity-referrals-auckland

    ... Referral forms Day Assessment Unit referral [PDF, 55 KB] [PDF, 55 KB] Day Assessment Unit ultrasound appointment [PDF, 11 KB] Email this form to DayAssessmentUnit@adhb.govt.nz Contact Contact the day assessment unit on: phone 09 307 4949 (extension 25907) fax: 630 9814 or ext 25908 Pathways, guidelines, policies, checklists Pathways, guidelines, policies, checklists Maternal Mental Health Liaison Policy [PDF, 1.2 MB] Funded NIPT PATHWAY [PDF, 431 KB] [PDF, 431 KB] Mental health pathway [PDF, 303 KB] LGA referral guideline [PDF, 509 KB] Hepatitis B flowchart [PDF, 202 KB] [PDF, 202 KB] Te Tok ...